NEW YORK, July 20: The U.S. Food and Drug Administration (FDA) has announced a major recall involving tens of thousands of Power Stick deodorants produced by A.P. Deauville due to manufacturing defects.

According to the agency, more than 67,000 cases of roll-on deodorants are affected by the recall, which was prompted by deviations from Current Good Manufacturing Practices (CGMP) — a set of industry standards that ensure quality and safety in pharmaceutical and personal care product manufacturing.

The recalled items include:

The deodorants were distributed across the United States. Consumers are encouraged to check the FDA’s website for specific lot numbers tied to the affected products.

While no press release has been issued by A.P. Deauville at this time, the recall is ongoing, and the FDA continues to monitor the situation.

“Recalls are important because they protect the public from products that may cause injury, illness, or even death,” the FDA stated in its notice. The agency emphasizes that staying informed about product recalls is essential for consumer safety.

Recalls can be initiated voluntarily by a manufacturer or at the request of the FDA. The agency notes that while many recalls result in products being pulled from the market, some issues can be corrected without removing products from distribution.

Between 2014 and 2024, more than 83,000 FDA-regulated products were recalled in the U.S.

For now, consumers in possession of the affected deodorants are advised to stop using them and refer to the FDA’s recall database for next steps.